Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Decision impact studies, evidence of clinical utility for genomic assays in cancer: A scoping review

10 Mar 2023

Abstract excerpt

BACKGROUND: Decision impact studies have become increasingly prevalent in cancer prognostic research in recent years. These studies aim to evaluate the impact of a genomic test on decision-making and appear to be a new form of evidence of clinical utility. The objectives of this review were to identify and characterize decision impact studies in genomic medicine in cancer care and categorize the types of clinical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA gene mutations in cancer
Share to Ethics in Clinical Research
Share to Health Systems, Economic Evaluations, Quality of Life

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36897859
DOI: 10.1371/journal.pone.0280582

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Decision impact studies, evidence of clinical utility for genomic assays in cancer: A scoping reviewPMID 36897859Read ↗

The Role of Decision Impact Studies in Genomic Medicine in Cancer Care: A Scoping Review and Bibliometric Analysis ProtocolSemantic proximity Read ↗

Genomic testing in oncology to improve clinical outcomes while optimizing utilization: the evolution of diagnostic testing.Semantic proximity Read ↗

Rate of change in investigational treatment options: An analysis of reports from a large precision oncology decision support effort.Semantic proximity Read ↗

High-impact trials with genetic and -omics information focus on cancer mutations, are industry-funded, and less transparent.Semantic proximity Read ↗

Supporting Biomarker-Driven Therapies in Oncology: A Genomic Testing Cost Calculator.Semantic proximity Read ↗

Next-generation sequencing in oncology: challenges in economic evaluations.Semantic proximity Read ↗

Genetic and other omics-based information in the most-cited recent clinical trialsSemantic proximity Read ↗

Stakeholder assessment of the evidence for cancer genomic tests: insights from three case studies.Semantic proximity Read ↗

Value-based genomicsSemantic proximity Read ↗

Genetic testing in cancer: a systematic review of patient reported measuresSemantic proximity Read ↗

Oncologist Confidence in Genomic Testing and Implications for Using Multimarker Tumor Panel Tests in PracticeSemantic proximity Read ↗

Evaluating the value of genomic diagnostics: implications for clinical practice and public policy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.